Studies from National Health Insurance Corporation Ilsan Hospital, Department of Ophthalmology in the area of diabetes therapy published
Scientists discuss in 'A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy' new findings in diabetes. In this recently published article, scientists in Korea conducted a study "To screen for diabetic autonomic neuropathy of the pupil using 0.5% apraclonidine and 0.1% pilocarpine and to evaluate the early diagnostic value of this pharmacologic pupillary test by assessing the relationship between pupillary and cardiovascular autonomic neuropathies. A total of 22 diabetic patients were recruited."
"Baseline pupillary diameter (PD) and the difference in PD between the test eye and the control eye before and after instillation of apraclonidine and pilocarpine were measured. All patients also underwent cardiovascular autonomic function (CAF) testing. Baseline PD in room light correlated with duration of diabetes mellitus (DM, p=0.049) and the presence of DM retinopathy (DMR, p=0.022). Eleven patients (50%) had positive apraclonidine tests, and two patients had positive pilocarpine tests. The patients who had positive pilocarpine tests also had positive apraclonidine tests. Patients who had a positive pupillary test had a significantly higher rate of positive CAF tests (p=0.032). Pupillary autonomic neuropathy was related to the duration of diabetes and the degree of DMR. There was also a significant correlation between pupillary autonomic neuropathy and cardiovascular autonomic neuropathy (CAN). Also, sympathetic nerve dysfunction occurred prior to parasympathetic dysfunction in this study," wrote H.J. Kwon and colleagues, National Health Insurance Corporation Ilsan Hospital, Department of Ophthalmology (see also Diabetes Therapy).
The researchers concluded: "A simple pharmacologic pupillary test can help manage complications in diabetic patients because patients with pupillary autonomic dysfunction have an increased risk of CAN."
Kwon and colleagues published their study in Korean Journal of Ophthalmology (A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. Korean Journal of Ophthalmology, 2009;23(4):291-5).
For more information, contact H.J. Kwon, National Health Insurance Corporation Ilsan Hospital, Dept. of Ophthalmology, #1232 Baekseok-dong, Ilsandong-gu, Goyang, Korea.


Advisor News
- How to listen to what your client isn’t saying
- Strong underwriting: what it means for insurers and advisors
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
More Advisor NewsAnnuity News
- MassMutual turns 175, Marking Generations of Delivering on its Commitments
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- My Annuity Store Launches a Free AI Annuity Research Assistant Trained on 146 Carrier Brochures and Live Annuity Rates
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
More Annuity NewsHealth/Employee Benefits News
- Reports Outline Clinical Trial Research Study Results from Imperial College London (Multimorbidity, health service use, and health insurance by socioeconomic groups in 31 countries: A multi-cohort study): Clinical Trial Research
- Findings from Brown University School of Public Health Broaden Understanding of Managed Care (Federal Enforcement Actions Against Medicare Advantage Plans): Managed Care
- Researchers at Brown University Warren Alpert Medical School Target Managed Care (The Aging World of Spinal Deformity Surgery: Epidemiological Trends Over A 12-Year Period): Managed Care
- NC parents and doctors push for insurance coverage for a medical test they say saves lives
- Georgia woman works through injuries as health insurance costs soar
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Berkshire Hathaway Life Insurance Company of Nebraska and First Berkshire Hathaway Life Insurance Company
- Generational expectations: A challenge for the industry
- Greg Lindberg asks NC judge for no jail time in bribery, fraud cases
- National Life Group Names Brenda Betts to Its Board of Directors
- Ask Tim a Question? Business, Finances, Money, or Taxes
More Life Insurance News